GB1345934A - Cyclopentane derivatives - Google Patents

Cyclopentane derivatives

Info

Publication number
GB1345934A
GB1345934A GB3304871A GB1345934DA GB1345934A GB 1345934 A GB1345934 A GB 1345934A GB 3304871 A GB3304871 A GB 3304871A GB 1345934D A GB1345934D A GB 1345934DA GB 1345934 A GB1345934 A GB 1345934A
Authority
GB
United Kingdom
Prior art keywords
reacting
furan
oxo
hexahydro
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3304871A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of GB1345934A publication Critical patent/GB1345934A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/367Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in singly bound form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/58Preparation of carboxylic acid halides
    • C07C51/60Preparation of carboxylic acid halides by conversion of carboxylic acids or their anhydrides or esters, lactones, salts into halides with the same carboxylic acid part
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1345934 Prosteglandin derivatives; phosphoric acid esters IMPERIAL CHEMICAL INDUSTRIES Ltd 13 June 1972 [14 July 1971] 33048/71 Headings C2C and C2P [Also in Divisions A5 and C3] The invention comprise prosteglandin derivatives of the formula wherein R<SP>1</SP> is hydroxymethyl, carboxyl or alkoxycarbonyl of up to 11 carbon atoms; either R<SP>2</SP> is OH or C 1-4 alkanoyloxy and R<SP>3</SP> is H, or R<SP>2</SP> and R<SP>3</SP> together form an oxo radical; A is -CH 2 CH 2 - or trans-CH=CH-; X is C 1-9 alkylene, and R<SP>4</SP> is C 1-9 alkyl or C 5-7 cycloalkyl provided that X and R<SP>4</SP> together contain not more than 10 carbon atoms, and for those compounds wherein R<SP>1</SP> is carboxy, pharmaceutically acceptable salts. Compounds of the above formula in which R<SP>1</SP> is carboxy are obtained by hydrolysing compounds of the formula or mixed anhydrides thereof, wherein R<SP>5</SP> and R<SP>6</SP> each are a tetrahydropyren-2-yloxy radical. The acids thus obtained may be converted to the corresponding esters by reacting them with diazoalkanes of the formula R<SP>7</SP>.N. 2 , wherein R<SP>7</SP> is C 1-10 alkyl, or reacting salts thereof with C 1-10 alkyl halides, and the esters reduced to compounds of the Formula I above in which R<SP>1</SP> is hydroxymethyl. 9α - Hydroxy - 16 - pentyloxy - 11α,15 - bis- (tetrahydropyran - 2 - yloxy) - 17,18,19,20- tetranor - 5 - cis,13 - trans - prostadienoic acid is prepared by reacting (4-carboxybutyl)triphenylphosphonium bromide with 3,3a#,4,5, 6,6a# - hexahydro - 2 - hydroxy - 4# - [4- pentyloxy - 3 - (tetrahydropyran - 2 - yloxy) - 1 - transbutenyl] - 5α - (tetrahydropyran - 2 - yloxy) 2H - cyclopenta[b]furan, obtained by reducing 3,3a#,4,5,6,6a# - hexahydro - 2 - oxo - 4# - [4- pentyloxy - 3 - (tetrahydropyran - 2 - yloxy) - 1- trans - butenyl] - 5α - (tetrahydropyran - 2 - yloxy)- 2H - cyclopenta[b]furan, resulting from the reaction between dihydropyran and 3,3a#,4,5,6, 6a# - hexahydro - 5α - hydroxy - 2 - oxo - 4#- (4 - pentyloxy - 3 - hydroxy - 1 - trans - butenyl)- 2H-cyclopenta[b]furan, which is made by hydrolysing 3,3a#,4,5,6,6a# - hexahydro - 2 - oxo - 4#- (4 - pentyloxy - 3 - hydroxy - 1 - trans - butenyl)- 5α - (4 - phenylbenzoyloxy) - 2H - cyclopenta[b]- furan obtained by reducing 3,3a,4,5,6,6a#- hexahydro - 2 - oxo - 4# - (3 - oxo - 4 - pentyloxy- 1 - trans - butenyl) - 5α - (4 - phenylbenzoyloxy)- 2H - cyclopenta[b]furan, resulting from the reaction between dimethyl 2-oxo-3-pentyloxypropylphosphonate and 5α - (4 - phenylbenzoyloxy) - 4# - formyl - 3,3a#,4,5,6,6a#- hexahydro - 2H - cyclopenta[b]furan - 2 one. The following compounds are prepared by reacting the appropriate phosphonate with 5α - (4 - phenylbenzoyloxy) - 4# - formyl- 3,3a#,4,5,6,6a# - hexahydrocyclo - 2H - penteno- [b]furan: 3,3a#,4,5,6,6a# - hexahydro - 5α - (4- phenylbenzoyloxy) - 4# - [3 - oxo - 4 - propoxy (or butoxy or isobutoxy, or hexyloxy) - 1 - transbutenyl], 2H-cyclopenteno[b]furan-2-one. 3,3a#,4,5,6,6a# - Hexahydro - 4# - (3 - oxo - 4- pentyloxybutyl) - 5α - (4 - phenylbenzoyloxy) - 2H- cyclopenteno[b]furan-2-one is obtained by hydrogenerating the corresponding unsaturated ketone. Butyl 3-butoxypropionate is prepared by reacting ethyl acrylate with a solution of sodium dissolved in n-butanol. Methyl 4-propoxybutyrate is obtained by esterifying 4-propoxybutyric acid, made by reacting 4- bromobutyric acid with a solution of sodium in n-propanol. Ethyl 5-ethoxypentanoate is made by hydrogenating ethyl 5-ethoxy-2-pentenoate obtained by reacting triethyl phosphonoacetate with 3- ethoxypropionaldehyde resulting from the hydrolysis of the corresponding diethyl acetal 6- methoxyhexanoyl chloride is prepared by reacting thionyl chloride with 6-methoxyhexanoic acid, resulting from the hydrolysis of ethyl 6-methoxyhexanoate, obtained by reacting ethyl 6-bromohexanoate and a solution of sodium in methanol. Phosphonates of the formula are prepared by reacting dimethyl methylphosphonate with compounds of the formula R<SP>4</SP>.O.XCOR<SP>5</SP>, where R<SP>5</SP> is alkoxy or halogen, in the presence of butyl-lithium.
GB3304871A 1971-07-14 1971-07-14 Cyclopentane derivatives Expired GB1345934A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3304871 1971-07-14

Publications (1)

Publication Number Publication Date
GB1345934A true GB1345934A (en) 1974-02-06

Family

ID=10347836

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3304871A Expired GB1345934A (en) 1971-07-14 1971-07-14 Cyclopentane derivatives

Country Status (13)

Country Link
JP (1) JPS5617344B1 (en)
AU (1) AU461617B2 (en)
BE (1) BE786250A (en)
CA (1) CA1093069A (en)
DD (1) DD102140A5 (en)
DE (1) DE2234708A1 (en)
FR (1) FR2145696B1 (en)
GB (1) GB1345934A (en)
HU (1) HU166718B (en)
IE (1) IE36421B1 (en)
NL (1) NL7209758A (en)
SE (1) SE7503704L (en)
ZA (1) ZA724234B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061671A (en) * 1974-04-03 1977-12-06 Hoechst Aktiengesellschaft Analogues of prostaglandins
US4113766A (en) * 1973-04-30 1978-09-12 Pfizer Inc. Oxaprostaglandins
US4169895A (en) 1976-09-28 1979-10-02 Pfizer Inc. Antisecretory 16,16-dimethyl-17-oxaprostaglandins
US4191774A (en) * 1978-01-18 1980-03-04 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. Novel 17-aza-PGF2α derivatives and pharmaceutical compositions containing the same

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4094899A (en) * 1972-06-02 1978-06-13 Pfizer Inc. Oxaprostaglandins

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4113766A (en) * 1973-04-30 1978-09-12 Pfizer Inc. Oxaprostaglandins
US4061671A (en) * 1974-04-03 1977-12-06 Hoechst Aktiengesellschaft Analogues of prostaglandins
US4169895A (en) 1976-09-28 1979-10-02 Pfizer Inc. Antisecretory 16,16-dimethyl-17-oxaprostaglandins
US4191774A (en) * 1978-01-18 1980-03-04 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. Novel 17-aza-PGF2α derivatives and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
BE786250A (en) 1973-01-15
ZA724234B (en) 1973-03-28
CA1093069A (en) 1981-01-06
NL7209758A (en) 1973-01-16
IE36421L (en) 1973-01-14
AU461617B2 (en) 1975-05-13
JPS5617344B1 (en) 1981-04-22
AU4376672A (en) 1974-01-03
SE7503704L (en) 1975-04-01
FR2145696B1 (en) 1976-04-16
DE2234708A1 (en) 1973-02-01
FR2145696A1 (en) 1973-02-23
HU166718B (en) 1975-05-28
IE36421B1 (en) 1976-10-27
DD102140A5 (en) 1973-12-05

Similar Documents

Publication Publication Date Title
EP0087237B1 (en) Carbacyclin analogues
GB1416410A (en) Prostaglandin anologues
GB1428137A (en) Prostanoic acid derivatives
GB1425961A (en) Prostanoic acid derivatives
GB1345934A (en) Cyclopentane derivatives
GB1356581A (en) Cyclopentane derivatives
IE36914L (en) Prostanoic acid derivatives.
ES454181A1 (en) Procedure for preparing an analogue of prostaglandine. (Machine-translation by Google Translate, not legally binding)
GB1386146A (en) Cyclopentane derivatives
GB1424417A (en) Prostaglandin intermediates and their preparation
GB1396207A (en) Prostaglandin intermediates and the preparation thereof
GB1398340A (en) Prostaglandins
GB1479964A (en) 2,3-methylene prostaglandins and their preparation
GB1333616A (en) Indene derivatives
GB1421553A (en) Process for the production of prostaglandins
US4533749A (en) 9-Substituted carbacyclin analogs
GB1424806A (en) Cyclopentane derivatives
GB1308650A (en) Cyclopropane carboxylic acid derivatives
GB1473670A (en) Process for the manufacture of prostaglandin-f2a and analogues thereof
GB1398347A (en) Prostaglandin intermediates
SE7601948L (en) METHODS OF PRODUCING CARBOXY-ALKANE-PHOSPHONIC ACIDS AND CARBOXY-ALKYL-PHOSPHINIC ACIDS
GB1356582A (en) Process for the manufacture of prostadienoic acid derivatives
US4590297A (en) Novel 9-substituted carbacyclin analogs
US4165325A (en) 11-Deoxy-trans-4,5,13,14-tetradehydro-PGI1 compounds
GB1529852A (en) 8-azaprostaglandins and process for the preparation thereof

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee